Victrex (LON:VCT) Sets New 52-Week High – Time to Buy?

Victrex plc (LON:VCT)’s stock price reached a new 52-week high during trading on Friday . The stock traded as high as GBX 754 and last traded at GBX 744.20, with a volume of 484513 shares. The stock had previously closed at GBX 725.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Canaccord Genuity Group downgraded Victrex to a “buy” rating and set a GBX 725 target price on the stock. in a research report on Friday, May 15th. Berenberg Bank boosted their price target on Victrex from GBX 600 to GBX 680 and gave the stock a “hold” rating in a research report on Wednesday, July 8th. UBS Group reissued a “sell” rating and issued a GBX 575 price objective on shares of Victrex in a research note on Monday, May 11th. Finally, Jefferies Financial Group restated a “hold” rating and issued a GBX 595 price objective on shares of Victrex in a report on Tuesday, July 7th. Two research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of GBX 663.33.

Victrex Stock Performance

The company has a market cap of £648.39 million, a PE ratio of -33.22, a PEG ratio of 1.92 and a beta of 0.77. The company has a debt-to-equity ratio of 21.30, a quick ratio of 1.99 and a current ratio of 2.35. The firm’s 50 day moving average is GBX 634.79 and its 200-day moving average is GBX 640.75.

Victrex (LON:VCT) last released its earnings results on Monday, May 11th. The company reported GBX 17.20 earnings per share for the quarter. The business had revenue of £147.10 million for the quarter. Victrex had a negative net margin of 6.70% and a negative return on equity of 4.95%. On average, research analysts anticipate that Victrex plc will post 73.1078905 earnings per share for the current fiscal year.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.